paramveer singh (@ParamMD) profile picture
Joined April 2017
15-20% appears to be over simplification. HCT-CI, CHARM scores can provide better estimate & discussions. 15-20% can be higher for healthy patient with no comorbdities and lower for patient with poor PS and comorbidities. I plug in best case scenario to CHARM & TRM < than 10%.
2
1
126
Replying to @Dr_AmerZeidan
seems clearly refractory to aza-ven the way blast count is rising. Day 11, WBC count is 3.1 in blood and absolute blast count is 2.6. would you agree, clear progression? no bone marrow done. Ven is 100, due to posa.
152
Insightful talk by @DholariaMD on allogeneic transplant outcomes in chronic neutrophilic leukemia from @CIBMTR @TheEBMT showing favorable outcome ➡️N 29 (excluded blastic phase) ➡️CSF3R (n =9), ASXL1 (n=4) ➡️1 yr NRM 10% ➡️1 yr OS 69%, 4yr 55% #DAVAWhistler @DAVAOnc #BMTsm
1
4
370
Insightful talk on #HLH after #CARTsm by Dr. Pullarkat @DAVAONC #DAVAWhistler 1️⃣dropping CRP after giving tocilizumab and rising ferritin useful finding to suspect HLH #pearl 2️⃣etoposide is not recommended as it can decrease the efficacy
2
5
696
workflow of outpatient CAR-T by @DhloraiaMD at @DAVAOnc #CARTsm
1
1
264
timing lymphodepletion in dialysis patients before CART therapy #CARTsm #onconephrology @DAVAOnc @Dr_AdrianaRossi #DAVAWhistler 1️⃣ chemo dose-adjusted for ESRD (e.g., flu 20 mg/m2 instead of 30 on days -5,-4,-3) 2️⃣ dialysis 12 h after each dose of chemo 3️⃣ N=2 PMID 35227310
2
4
378
post-CART DLBCL approach by Dr. Kamdar @DAVAOnc @mana1981 #llysm #CARTsm ➡️Clinical trial, preferably BiTE ➡️Lonca, Tafa-Len if CD19 positive.
2
1
377
Replying to @MediHumdani
I voted for w/w @UpToDate approach feels a bit aggressive. #1/
1
245
Replying to @DAielloMD
let's say you started chemo-IO and the MET exon result came back later, most oncologist would continue with chemo-IO or switch to capmatinib? I am seeing many "OR" in NCCN guidelines. attaching a screenshot here. @dipeshuprety4
2
1
3
575